{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:20:07Z","timestamp":1788787207191,"version":"build-2803163510"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Lung adenocarcinoma (LUAD) is a prevalent form of lung cancer globally, known for its high invasiveness, metastatic potential, and notable heterogeneity, particularly in its response to immunotherapy. Gremlin 1 (GREM1) is implicated in tumor progression and poor prognosis in multiple cancers. However, GREM1\u2019s specific role in LUAD remains unclear. This study systematically examines GREM1 expression in LUAD and its association with tumor progression, immune microenvironment, and prognosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Gene expression data from the TCGA and GSE31210 databases were analyzed using Weighted Gene Co-expression Network Analysis (WGCNA), GO and KEGG enrichment analyses. The prognostic value of GREM1 was evaluated through survival analysis, Cox regression, and Kaplan-Meier curves. Additionally, immune microenvironment analysis was conducted to explore the relationship between GREM1 and immune cell infiltration. <jats:italic>In vitro<\/jats:italic> experiments, including Western blot and assays for cell proliferation, migration, and invasion, were performed to confirm the specific role of GREM1 in LUAD cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>GREM1 was significantly upregulated in tumor tissues and correlated with poor prognosis. Moreover, GREM1 was significantly associated with immune cell infiltration and immunotherapy response within the immune microenvironment. <jats:italic>In vitro<\/jats:italic> experiments confirmed that GREM1 overexpression significantly promoted LUAD cell proliferation, migration, and epithelial-mesenchymal transition (EMT), whereas GREM1 knockdown suppressed these functions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>A comprehensive analysis indicates that GREM1 is crucial in LUAD progression, with its overexpression predicting poor prognosis. GREM1 could be a potential therapeutic target for LUAD, providing insights for personalized therapy optimization.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1529195","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:33:23Z","timestamp":1740378803000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["A comprehensive prognostic and immunological implications of Gremlin 1 in lung adenocarcinoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Hongyan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13045-023-01436-2","article-title":"Emerging evidence and treatment paradigm of non-small cell lung cancer","volume":"16","author":"Liu","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-0237-9","article-title":"Guidelines and definitions for research on epithelial\u2013mesenchymal transition","volume":"21","author":"Yang","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2017.05.040","article-title":"HGF induces EMT in non-small-cell lung cancer through the hBVR pathway","volume":"811","author":"Liu","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01497","article-title":"First-line immunotherapy for non\u2013small-cell lung cancer","volume":"40","author":"Reck","year":"2022","journal-title":"J Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01740-y","article-title":"Lung cancer immunotherapy: progress, pitfalls, and promises","volume":"22","author":"Lahiri","year":"2023","journal-title":"Mol Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nature07085","article-title":"An Fgf\/Gremlin inhibitory feedback loop triggers termination of limb bud outgrowth","volume":"454","author":"Verheyden","year":"2008","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/biomedicines10020301","article-title":"Insights into the role of gremlin-1, a bone morphogenic protein antagonist, in cancer initiation and progression","volume":"10","author":"Elemam","year":"2022","journal-title":"Biomedicines"},{"key":"B12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13058-019-1194-0","article-title":"Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression","volume":"21","author":"Ren","year":"2019","journal-title":"Breast Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04888-7","article-title":"GREM1 is required to maintain cellular heterogeneity in pancreatic cancer","volume":"607","author":"Lan","year":"2022","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.3390\/cells11142136","article-title":"Gremlin-1 promotes colorectal cancer cell metastasis by activating ATF6 and inhibiting ATF4 pathways","volume":"11","author":"Li","year":"2022","journal-title":"Cells"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-022-00380-3","article-title":"Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer","volume":"3","author":"Cheng","year":"2022","journal-title":"Nat Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-021-03964-x","article-title":"Gremlin: a complex molecule regulating wound healing and fibrosis","volume":"78","author":"O\u2019reilly","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s43152-023-00052-z","article-title":"Tumor microenvironment regulates immune checkpoints: emerging need of combinatorial therapies","volume":"5","author":"Kalia","year":"2024","journal-title":"Curr Tissue Microenviron Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153821","article-title":"He-Chan Pian inhibits the metastasis of non-small cell lung cancer via the miR-205-5p-mediated regulation of the GREM1\/Rap1 signaling pathway","volume":"94","author":"Kan","year":"2022","journal-title":"Phytomedicine"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12967-023-04705-3","article-title":"A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer","volume":"22","author":"Mason","year":"2024","journal-title":"J Transl Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12964-019-0467-7","article-title":"GREM1 is associated with metastasis and predicts poor prognosis in ER-negative breast cancer patients","volume":"17","author":"Neckmann","year":"2019","journal-title":"Cell Commun Signal"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-022-00381-2","article-title":"There are gremlins in prostate cancer","volume":"3","author":"Sena","year":"2022","journal-title":"Nat Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-74","article-title":"The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein","volume":"6","author":"Namkoong","year":"2006","journal-title":"BMC Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.951582","article-title":"Integrative analysis from multicenter studies identifies a WGCNA-derived cancer-associated fibroblast signature for ovarian cancer","volume":"13","author":"Feng","year":"2022","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13059-020-02019-x","article-title":"A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk","volume":"21","author":"Gentles","year":"2020","journal-title":"Genome Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1053\/j.gastro.2020.11.011","article-title":"The balance of stromal BMP signaling mediated by GREM1 and ISLR drives colorectal carcinogenesis","volume":"160","author":"Kobayashi","year":"2021","journal-title":"Gastroenterology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2014.12.004","article-title":"BMP signalling: agony and antagony in the family","volume":"25","author":"Brazil","year":"2015","journal-title":"Trends Cell Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.02.017","article-title":"Reciprocal modulation of mesenchymal stem cells and tumor cells promotes lung cancer metastasis","volume":"29","author":"Fregni","year":"2018","journal-title":"eBioMedicine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.ccell.2018.03.018","article-title":"Genomic features of response to combination immunotherapy in patients with advanced non-small-cell lung cancer","volume":"33","author":"Hellmann","year":"2018","journal-title":"Cancer Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar3593","article-title":"Pan-tumor genomic biomarkers for PD-1 checkpoint blockade\u2013based immunotherapy","volume":"362","author":"Cristescu","year":"2018","journal-title":"Science"},{"key":"B32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12935-024-03422-1","article-title":"miR-455\/GREM1 axis promotes colorectal cancer progression and liver metastasis by affecting PI3K\/AKT pathway and inducing M2 macrophage polarization","volume":"24","author":"Dai","year":"2024","journal-title":"Cancer Cell Int"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00920-6","article-title":"Gremlin 1+ fibroblastic niche maintains dendritic cell homeostasis in lymphoid tissues","volume":"22","author":"Kapoor","year":"2021","journal-title":"Nat Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2018.4573","article-title":"Overexpression of Gremlin 1 by sonic hedgehog signaling promotes pancreatic cancer progression","volume":"53","author":"Yu","year":"2018","journal-title":"Int J Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.21873\/cgp.20167","article-title":"Increased expression of gremlin1 promotes proliferation and epithelial mesenchymal transition in gastric cancer cells and correlates with poor prognosis of patients with gastric cancer","volume":"17","author":"Sun","year":"2020","journal-title":"Cancer Genomics - Proteom"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1159\/000491060","article-title":"Gremlin1 delivered by mesenchymal stromal cells promoted epithelial-mesenchymal transition in human esophageal squamous cell carcinoma","volume":"47","author":"Hong","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12935-019-0852-8","article-title":"Overexpression of mircoRNA-137 inhibits cervical cancer cell invasion, migration and epithelial\u2013mesenchymal transition by suppressing the TGF-\u03b2\/smad pathway via binding to GREM1","volume":"19","author":"Miao","year":"2019","journal-title":"Cancer Cell Int"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/mc.23416","article-title":"CAF-derived exosomes transmitted Gremlin-1 promotes cancer progression and decreases the sensitivity of hepatoma cells to sorafenib","volume":"61","author":"Qin","year":"2022","journal-title":"Mol Carcinog"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1116305","article-title":"Comprehensive analysis of cuproptosis-related genes on bladder cancer prognosis, tumor microenvironment invasion, and drug sensitivity","volume":"13","author":"Wang","year":"2023","journal-title":"Front Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer","volume":"54","author":"Ozga","year":"2021","journal-title":"Immunity"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159010","article-title":"Gremlin-1 overexpression in mouse lung reduces silica-induced lymphocyte recruitment \u2013 A link to idiopathic pulmonary fibrosis through negative correlation with CXCL10 chemokine","volume":"11","author":"Koli","year":"2016","journal-title":"PloS One"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2020.05.001","article-title":"Pancreatic stromal Gremlin 1 expression during pancreatic tumorigenesis","volume":"9","author":"Davis","year":"2022","journal-title":"Genes Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2013.04.002","article-title":"Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1","volume":"7","author":"Karagiannis","year":"2013","journal-title":"Mol Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-023-01744-8","article-title":"Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments","volume":"22","author":"Yuan","year":"2023","journal-title":"Mol Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.10.025","article-title":"Gremlin-1 activates Akt\/STAT3 signaling, which increases the glycolysis rate in breast cancer cells","volume":"533","author":"Kim","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B46","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12957-023-03128-0","article-title":"GREM1 is a potential biomarker for the progression and prognosis of bladder cancer","volume":"21","author":"Jiang","year":"2023","journal-title":"World J Surg Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15972","article-title":"Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data","volume":"24","author":"Wang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12881-019-0909-5","article-title":"Copy number variation is highly correlated with differential gene expression: a pan-cancer study","volume":"20","author":"Shao","year":"2019","journal-title":"BMC Med Genet"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s12079-023-00777-4","article-title":"GREM1 signaling in cancer: tumor promotor and suppressor","volume":"17","author":"Gao","year":"2023","journal-title":"J Cell Commun Signal"},{"key":"B50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nm.3750","article-title":"Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche","volume":"21","author":"Davis","year":"2015","journal-title":"Nat Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"9227","DOI":"10.3390\/ijms21239227","article-title":"Gremlin-1 promotes metastasis of breast cancer cells by activating STAT3-MMP13 signaling pathway","volume":"21","author":"Sung","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"199","DOI":"10.7150\/jca.36886","article-title":"Prognostic and clinicopathological significance of Hapto and Gremlin1 expression in extrahepatic cholangiocarcinoma","volume":"11","author":"Wu","year":"2020","journal-title":"J Cancer"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.968610","article-title":"GREM1 is a novel serum diagnostic marker and potential therapeutic target for pancreatic ductal adenocarcinoma","volume":"12","author":"Yang","year":"2022","journal-title":"Front Oncol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2023.2289681","article-title":"Discovery of ginisortamab, a potent and novel anti-gremlin-1 antibody in clinical development for the treatment of cancer","volume":"15","author":"Davies","year":"2023","journal-title":"MAbs"},{"key":"B55","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13073-023-01229-9","article-title":"Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome","volume":"15","author":"Sun","year":"2023","journal-title":"Genome Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-RW2022-0124","article-title":"GREM1 restricts plasticity and maintains heterogeneity in pancreatic cancer","volume":"12","year":"2022","journal-title":"Cancer Discovery"},{"key":"B57","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3892\/mco.2023.2665","article-title":"Current status and prospects of GREM1 research in cancer (Review)","volume":"19","author":"Zhu","year":"2023","journal-title":"Mol Clin Oncol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"23280","DOI":"10.1038\/s41598-024-73655-7","article-title":"GREM1 may be a biological indicator and potential target of bladder cancer","volume":"14","author":"Yu","year":"2024","journal-title":"Sci Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1529195\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:33:33Z","timestamp":1740378813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1529195\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":58,"alternative-id":["10.3389\/fimmu.2025.1529195"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1529195","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"article-number":"1529195"}}